Tarsus Pharmaceuticals

About:

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.

Website: https://www.tarsusrx.com

Twitter/X: TarsusRx

Top Investors: Frazier Healthcare Partners, Vivo Capital, Aperture Venture Partners, Armentum Partners, BioPharma Credit

Description:

Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.